Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Ladies and gentlemen, greetings, and welcome to the KORU Medical ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

Since its initial public offering, Convatec has followed a familiar playbook to press its advantage in advanced wound care and to enhance its ostomy business. By and large, we like Convatec’s ...

We will be filing our Form 10-Q with the SEC in the next few ... As previously mentioned, we have initial production ...

STOUGHTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified ...

Operator: Good morning, ladies and gentlemen, and welcome to the Nortech Systems Incorporated Third Quarter 2024 Earnings ...

Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ETCompany ParticipantsEric Brock - Chairman and CEONeil Laird ...

This is not a “how-to” episode, nor meant to be any form of advice ... things we should already have on hand—in inventory. Prepping is just making sure you have all that, along with an emergency ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

In this conversation with Medline CEO Jim Boyle, he outlines the strategy health systems need to build a resilient supply ...